Results 1 to 10 of about 328,568 (91)

Basics of Immunohistochemistry [PDF]

Journal of Investigative Dermatology, 2015
INTRODUCTION Immunohistochemistry (IHC) is a powerful method for localizing specific antigens in formalin-fixed, paraffin-embedded (FFPE) tissues based on antigen–antibody interaction (Taylor and Burns, 1974). The technique is widely used in dermatologic diagnostics and research, and its applications continue to be extended because of its ease of use ...
Johannes S. Kern, Vivien Schacht
openaire   +3 more sources

Immunohistochemistry [PDF]

WormBook, 2006
Immunohistochemistry allows specific proteins to be visualized while retaining cellular or tissue structure. Sensitivity of the technique has improved over the years from a single layer of labeled antibody to amplified, labeled polymer-based systems, which enable low levels of antigen to be detected in different types of tissue preparation.
openaire   +4 more sources

Functional characterization of human thyroid tissue with immunohistochemistry [PDF]

, 2007
Immunohistochemistry provides insights in the expression of functional proteins and of their localization in normal thyroid tissue and in thyroid diseases.
Bernard, Caillou, Faggiano, Antongiulio, Filetti, Sebastiano, Jean Michel Bidart,, Ludovic, Lacroix, Martin, Schlumberger, Monique, Talbot   +6 more
core   +1 more source

Rapid micro-immunohistochemistry [PDF]

Microsystems & Nanoengineering, 2020
AbstractWe present a new and versatile implementation of rapid and localized immunohistochemical staining of tissue sections. Immunohistochemistry (IHC) comprises a sequence of specific biochemical reactions and allows the detection of specific proteins in tissue sections.
Robert D. Lovchik, David Taylor, Govind Kaigala   +2 more
openaire   +5 more sources

Immunohistochemistry

Journal of Pathology of Nepal, 2015
Immunohistochemistry (IHC) or immunocytochemistry is a method of localizing specific antigen in tissue or cells based on antigen antibody reaction. IHC is the way of validating morphological findings. It helps in tumor diagnosis and classification, identify prognostic and predictive markers.
Clive R. Taylor, Richard J. Cote
  +7 more sources

Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis [PDF]

, 2012
Extracellular matrix deposition and tissue scarring characterize the process of fibrosis. Transforming growth factor beta (TGFβ) and Insulin-like growth factor binding protein-3 (IGFBP-3) have been implicated in the pathogenesis of fibrosis in various ...
Adriana T. Larregina, Carol A. Feghali-Bostwick, Joseph M. Pilewski, Logan R. Mlakar, Sebastien Fuchs, Ximena D. Ruiz, Yukie Yamaguchi, Yunyun Su   +7 more
core   +10 more sources

Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997 [PDF]

, 2009
Using archived tumours, those from 1984-1986 and 1996-1997 underwent immunohistochemistry for hormone receptors and grade analysis. A significant shift towards more ER-positive and low-grade disease was found; this appears to reflect screening practices,
AG Glass, B Elsberger, CI Li, CS Thomson, E A Mallon, F M Campbell, GA Colditz, J Edwards, JD Potter, L M McGlynn, L Tabar, MJ Bradburn, P Pujol, S B F Brown, SBF Brown, T G Cooke, T Kirkegaard   +16 more
core   +2 more sources

Applications of immunohistochemistry

Journal of Pharmacy And Bioallied Sciences, 2012
Immunohistochemistry (IHC) is an important application of monoclonal as well as polyclonal antibodies to determine the tissue distribution of an antigen of interest in health and disease. IHC is widely used for diagnosis of cancers; specific tumor antigens are expressed de novo or up-regulated in certain cancers.
Rajeshwar Govindarajan, Murugesan Palanisamy, Jeyapradha Duraiyan, Karunakaran Kaliyappan   +3 more
openaire   +4 more sources

A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma [PDF]

, 2017
Aims: CDX2 is widely used as a sensitive and specific immunomarker for colorectal carcinoma (CRC) but neither this sensitivity nor specificity is absolute. This study is the first known comparison of CDX1 and A33 against CDX2 as immunomarkers for CRC.
Adamczyk, Lukasz A., Cullen, Jayne, Evans, Shanna, Oien, Karin A., Oniscu, Anca, Wong, Newton A.C.S.   +5 more
core   +1 more source

The novel MAPT mutation K298E:mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons [PDF]

, 2013
Frontotemporal lobar degeneration (FTLD) consists of a group of neurodegenerative diseases characterized by behavioural and executive impairment, language disorders and motor dysfunction.
Calo, Laura, Goedert, Michel, Holton, Janice L., Iovino, Mariaangela, Lashley, Tammaryn, Muqit, Miratul M. K., Parmar, Malin, Pfisterer, Ulrich, Revesz, Tamas, Spillantini, Maria Grazia, Swingler, Robert J., Treacy, Rebecca   +11 more
core   +3 more sources